NO993076D0 - FremgangsmÕte for krystallisering av et tetrahydro-pyridinderivat og resulterende krystallinske former - Google Patents
FremgangsmÕte for krystallisering av et tetrahydro-pyridinderivat og resulterende krystallinske formerInfo
- Publication number
- NO993076D0 NO993076D0 NO993076A NO993076A NO993076D0 NO 993076 D0 NO993076 D0 NO 993076D0 NO 993076 A NO993076 A NO 993076A NO 993076 A NO993076 A NO 993076A NO 993076 D0 NO993076 D0 NO 993076D0
- Authority
- NO
- Norway
- Prior art keywords
- crystallizing
- crystalline forms
- resulting crystalline
- tetrahydropyridine derivative
- tetrahydropyridine
- Prior art date
Links
- VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical class C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9615904A FR2757543B1 (fr) | 1996-12-23 | 1996-12-23 | Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues |
| PCT/FR1997/002393 WO1998028271A1 (fr) | 1996-12-23 | 1997-12-23 | Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO993076D0 true NO993076D0 (no) | 1999-06-22 |
| NO993076L NO993076L (no) | 1999-06-22 |
| NO312364B1 NO312364B1 (no) | 2002-04-29 |
Family
ID=9499043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19993076A NO312364B1 (no) | 1996-12-23 | 1999-06-22 | Fremgangsmåte for krystallisering av et tetrahydro- pyridinderivat og resulterende krystallinske former |
Country Status (38)
| Country | Link |
|---|---|
| EP (1) | EP0950050B1 (no) |
| JP (2) | JP4499188B2 (no) |
| KR (1) | KR100586670B1 (no) |
| CN (1) | CN1129580C (no) |
| AR (1) | AR009672A1 (no) |
| AT (1) | ATE307802T1 (no) |
| AU (1) | AU736697B2 (no) |
| BR (1) | BR9714081A (no) |
| CA (1) | CA2275596C (no) |
| CO (1) | CO5070688A1 (no) |
| CZ (1) | CZ296689B6 (no) |
| DE (1) | DE69734460T2 (no) |
| DK (1) | DK0950050T3 (no) |
| DZ (1) | DZ2383A1 (no) |
| EE (1) | EE04188B1 (no) |
| EG (1) | EG21567A (no) |
| ES (1) | ES2251038T3 (no) |
| FR (1) | FR2757543B1 (no) |
| HR (1) | HRP970699B1 (no) |
| HU (1) | HU227425B1 (no) |
| IL (1) | IL129938A (no) |
| IN (1) | IN186976B (no) |
| IS (1) | IS2357B (no) |
| MY (1) | MY118015A (no) |
| NO (1) | NO312364B1 (no) |
| NZ (1) | NZ336130A (no) |
| PL (1) | PL190494B1 (no) |
| RS (1) | RS49882B (no) |
| RU (1) | RU2192416C2 (no) |
| SA (1) | SA98180971B1 (no) |
| SI (1) | SI0950050T1 (no) |
| SK (1) | SK285088B6 (no) |
| TR (1) | TR199901363T2 (no) |
| TW (1) | TW518322B (no) |
| UA (1) | UA60324C2 (no) |
| UY (1) | UY24825A1 (no) |
| WO (1) | WO1998028271A1 (no) |
| ZA (1) | ZA9711576B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2757543B1 (fr) * | 1996-12-23 | 1999-04-02 | Sanofi Sa | Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues |
| FR2782082B3 (fr) * | 1998-08-05 | 2000-09-22 | Sanofi Sa | Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose |
| JP5504334B2 (ja) | 2010-03-12 | 2014-05-28 | 株式会社日本触媒 | 吸水性樹脂の製造方法 |
| EP2643294B1 (en) * | 2011-04-15 | 2016-08-24 | Emcure Pharmaceuticals Limited | An improved rilpivirine process |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2531707A1 (fr) * | 1982-08-16 | 1984-02-17 | Midy Spa | Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques |
| FR2757543B1 (fr) * | 1996-12-23 | 1999-04-02 | Sanofi Sa | Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues |
-
1996
- 1996-12-23 FR FR9615904A patent/FR2757543B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-19 AR ARP970106029A patent/AR009672A1/es not_active Application Discontinuation
- 1997-12-22 HR HR970699A patent/HRP970699B1/xx not_active IP Right Cessation
- 1997-12-22 MY MYPI97006233A patent/MY118015A/en unknown
- 1997-12-22 DZ DZ970233A patent/DZ2383A1/xx active
- 1997-12-23 NZ NZ336130A patent/NZ336130A/xx not_active IP Right Cessation
- 1997-12-23 IL IL12993897A patent/IL129938A/en not_active IP Right Cessation
- 1997-12-23 EG EG138397A patent/EG21567A/xx active
- 1997-12-23 HU HU0001387A patent/HU227425B1/hu not_active IP Right Cessation
- 1997-12-23 IN IN3761DE1997 patent/IN186976B/en unknown
- 1997-12-23 AT AT97952986T patent/ATE307802T1/de active
- 1997-12-23 RS YUP-289/99A patent/RS49882B/sr unknown
- 1997-12-23 DK DK97952986T patent/DK0950050T3/da active
- 1997-12-23 TR TR1999/01363T patent/TR199901363T2/xx unknown
- 1997-12-23 UA UA99063521A patent/UA60324C2/uk unknown
- 1997-12-23 SK SK828-99A patent/SK285088B6/sk not_active IP Right Cessation
- 1997-12-23 JP JP52848198A patent/JP4499188B2/ja not_active Expired - Fee Related
- 1997-12-23 WO PCT/FR1997/002393 patent/WO1998028271A1/fr not_active Ceased
- 1997-12-23 CO CO97074792A patent/CO5070688A1/es unknown
- 1997-12-23 PL PL97334256A patent/PL190494B1/pl not_active IP Right Cessation
- 1997-12-23 BR BR9714081-3A patent/BR9714081A/pt not_active Application Discontinuation
- 1997-12-23 RU RU99116597/04A patent/RU2192416C2/ru not_active IP Right Cessation
- 1997-12-23 CA CA002275596A patent/CA2275596C/en not_active Expired - Fee Related
- 1997-12-23 ZA ZA9711576A patent/ZA9711576B/xx unknown
- 1997-12-23 SI SI9730720T patent/SI0950050T1/sl unknown
- 1997-12-23 KR KR1019997005373A patent/KR100586670B1/ko not_active Expired - Fee Related
- 1997-12-23 ES ES97952986T patent/ES2251038T3/es not_active Expired - Lifetime
- 1997-12-23 AU AU56684/98A patent/AU736697B2/en not_active Ceased
- 1997-12-23 EE EEP199900264A patent/EE04188B1/xx not_active IP Right Cessation
- 1997-12-23 CN CN97180863A patent/CN1129580C/zh not_active Expired - Fee Related
- 1997-12-23 EP EP97952986A patent/EP0950050B1/fr not_active Expired - Lifetime
- 1997-12-23 CZ CZ0229299A patent/CZ296689B6/cs not_active IP Right Cessation
- 1997-12-23 UY UY24825A patent/UY24825A1/es not_active IP Right Cessation
- 1997-12-23 DE DE69734460T patent/DE69734460T2/de not_active Expired - Lifetime
-
1998
- 1998-01-21 TW TW086119629A patent/TW518322B/zh not_active IP Right Cessation
- 1998-03-11 SA SA98180971A patent/SA98180971B1/ar unknown
-
1999
- 1999-06-10 IS IS5076A patent/IS2357B/is unknown
- 1999-06-22 NO NO19993076A patent/NO312364B1/no not_active IP Right Cessation
-
2009
- 2009-05-07 JP JP2009112971A patent/JP2009197022A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA962200B (en) | Piperidine derivatives | |
| FI956270L (fi) | Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi | |
| NO180484C (no) | Fremgangsmåte for fremstilling av substituerte piperidiner | |
| HUP9903454A3 (en) | A crystalline form of cefditoren pivoxyl and process for the production of the same | |
| NO993006D0 (no) | FremgangsmÕte for separering av paraxylen omfattende et adsorpsjonstrinn med injeksjon av vann og et krystallisasjonstrinn | |
| FI933391A7 (fi) | Triatsolyylitiometyylitio-kefalosporiini-hydrokloridi, sen kiteytetty hydraatti sekä menetelmä niiden valmistamiseksi | |
| DE69620107D1 (de) | Kristallisationsverfahren | |
| NO944290D0 (no) | Fremgangsmåte for undersökelse av et brönnhull | |
| NO944289L (no) | Fremgangsmåte for undersökelse av et brönnhull | |
| NO932915L (no) | Mikroporöst krystallinsk silikoaluminofosfat og fremgangsmåte for fremstilling av dette | |
| DK0842170T3 (da) | Diphenylmethylen-piperidin-derivater | |
| DK0734382T3 (da) | Krystallinske N-acetyl-neuraminsyrederivater og fremgangsmåder til deres fremstilling | |
| HUT74163A (en) | New crystalline cepheme-acid-addicional salts and process for producing them | |
| NO993076L (no) | Fremgangsmåte for krystallisering av et tetrahydro-pyridinderivat og resulterende krystallinske former | |
| FI942288L (fi) | Menetelmä sulakkeen valmistamiseksi | |
| EP1076064A4 (en) | NEW ASPARTAME DERIVATIVE CRYSTAL AND MANUFACTURING METHOD THEREOF | |
| AU7104596A (en) | Piperidine derivatives and processes for their production | |
| MD254B1 (ro) | Procedeu de cultivare a marului | |
| GB9516767D0 (en) | Process for producing piperidine derivatives | |
| MD940028A (ro) | Procedeu de obtinere a tilozinei cristalice | |
| HU9203562D0 (en) | Benzoquinoxaline derivatives and method for producing them | |
| EP1076063A4 (en) | Novel crystal of an aspartame derivative and process for its manufacture | |
| HUP9702472A3 (en) | Process for producing allyl-amine derivative and salts thereof | |
| FI940326A0 (fi) | Menetelmä turvetuotteen valmistamiseksi | |
| NO963437D0 (no) | Fremgangsmåte og innretning for montering av en verktöystreng |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |